Genetic variations in CTLA-4, TNF-α, and LTA and susceptibility to T-cell lymphoma in a Chinese population-Reference-Cited by-同舟云学术

Genetic variations in CTLA-4, TNF-α, and LTA and susceptibility to T-cell lymphoma in a Chinese population

Published:2013-12 Issue:6 Volume:37 Page:930-934
ISSN:1877-7821
Container-title:Cancer Epidemiology
language:en
Short-container-title:Cancer Epidemiology

Author:

Liu Jie,Liu Jing,Song Bao,Wang Ti,Liu Yuhong,Hao Jing,Yu Jinming

Funder

Shandong Provincial Science Technology Foundation

Shandong Healthy Department Foundation

Jinan Science Research Project Foundation

Shandong Provincial Natural Science Foundation, China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Epidemiology

Reference31 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Pathological and clinical characteristics of 1,248 non-Hodgkin's lymphomas from a regional cancer hospital in Shandong, China;Liu;Asian Pac J Cancer Prev,2011

3. Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases;Laurini;Blood,2012

4. Unraveling the interactions between environmental factors and genetic polymorphisms in non-Hodgkin lymphoma risk;Wang;Expert Rev Anticancer Ther,2010

5. Genetic susceptibility to lymphoma;Skibola;Haematologica,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ANTÍGENO LEUCOCITÁRIO HUMANO DE CLASSE III: REVISÃO INTEGRATIVA;RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218;2024-03-04

2. Genetic predisposition to early mycosis fungoides: investigating genetic polymorphisms in tissue-resident memory T-cell genes;Journal of International Medical Research;2024-03

3. Lymphotoxin;Reference Module in Life Sciences;2024

4. Impact of the cytotoxic T-lymphocyte associated antigen-4 rs231775 A/G polymorphism on cancer risk;Heliyon;2023-12

5. Comprehensive Analysis of 29,464 Cancer Cases and 35,858 Controls to Investigate the Effect of the Cytotoxic T-Lymphocyte Antigen 4 Gene rs231775 A/G Polymorphism on Cancer Risk;Frontiers in Oncology;2022-05-04